Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. Mai 2009 09:00 ET | Quelle: Asubio Pharmaceuticals, Inc.

Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy

ROCHELLE PARK, N.J., May 14, 2009 (GLOBE NEWSWIRE) -- Asubio Pharmaceuticals, Inc. will present new data on the efficacy and safety of Piclozotan in improving both dyskinesia and OFF time in...
14. Mai 2009 09:00 ET | Quelle: Asubio Pharmaceuticals, Inc.

Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy

Asubio Pharmaceuticals, Inc. to Present Data At the Movement Disorder Society's 13th International Congress of Parkinson's Disease and Movement Disorders ROCHELLE PARK, N.J., May 14, 2009 (GLOBE...
15. Januar 2008 12:06 ET | Quelle: Asubio Pharmaceuticals, Inc.

Study Shows Carperitide Significantly Reduces Cardiac Death and Improves Outcomes in Acute Myocardial Infarction

ROCHELLE PARK, N.J., Jan. 15, 2008 (PRIME NEWSWIRE) -- According to an independent study published in the Lancet in October 2007, carperitide (human atrial natriuretic peptide) significantly reduced...